本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

T2 Biosystems

0.1627
+0.01268.39%
成交量:7.19万
成交额:1.18万
市值:456.30万
市盈率:-0.04
高:0.1700
开:0.1550
低:0.1550
收:0.1501
数据加载中...
2024/09/09

重要事件披露

Form 8-K - Current report
2024/08/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/29

重要事件披露

Form 8-K - Current report
2024/07/27

SEC问询函

Form CORRESP - Correspondence
2024/07/19

重要事件披露

Form 8-K - Current report
2024/06/01

SEC问询函

Form CORRESP - Correspondence
2024/05/22

重要事件披露

Form 8-K - Current report
2024/05/20

重要事件披露

Form 8-K - Current report
2024/05/14

重要事件披露

Form 8-K - Current report
2024/05/13

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/05/08

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/05/07

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/05/07

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/05/07

重要事件披露

Form 8-K - Current report
2024/05/07

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/05/06

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/05/06

重要事件披露

Form 8-K - Current report
2024/05/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]